These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26072409)

  • 1. Oncolytic Viral Therapy Using Reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
    PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
    Zhao X; Chester C; Rajasekaran N; He Z; Kohrt HE
    Mol Cancer Ther; 2016 May; 15(5):767-73. PubMed ID: 27197256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
    Mohamed A; Johnston RN; Shmulevitz M
    Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
    Shmulevitz M; Lee PW
    Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncanonical Cell Death Induction by Reassortant Reovirus.
    Rodríguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reovirus: Rationale and clinical trial update.
    Lal R; Harris D; Postel-Vinay S; de Bono J
    Curr Opin Mol Ther; 2009 Oct; 11(5):532-9. PubMed ID: 19806501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reovirus-based therapy for cancer.
    Kelly K; Nawrocki S; Mita A; Coffey M; Giles FJ; Mita M
    Expert Opin Biol Ther; 2009 Jul; 9(7):817-30. PubMed ID: 19527106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.
    Rodríguez Stewart RM; Berry JTL; Berger AK; Yoon SB; Hirsch AL; Guberman JA; Patel NB; Tharp GK; Bosinger SE; Mainou BA
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.
    Thirukkumaran CM; Nodwell MJ; Hirasawa K; Shi ZQ; Diaz R; Luider J; Johnston RN; Forsyth PA; Magliocco AM; Lee P; Nishikawa S; Donnelly B; Coffey M; Trpkov K; Fonseca K; Spurrell J; Morris DG
    Cancer Res; 2010 Mar; 70(6):2435-44. PubMed ID: 20215509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reovirus therapy in cancer: has the orphan virus found a home?
    Yap TA; Brunetto A; Pandha H; Harrington K; Debono JS
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1925-35. PubMed ID: 19012507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reovirus modulates autophagy during oncolysis of multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Autophagy; 2013 Mar; 9(3):413-4. PubMed ID: 23322106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
    Shmulevitz M; Marcato P; Lee PW
    Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reovirus oncolysis of human breast cancer.
    Norman KL; Coffey MC; Hirasawa K; Demetrick DJ; Nishikawa SG; DiFrancesco LM; Strong JE; Lee PW
    Hum Gene Ther; 2002 Mar; 13(5):641-52. PubMed ID: 11916487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
    Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
    Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Reoviral Cytolysis (I): Combination Therapeutics.
    Mori Y; Nishikawa SG; Fratiloiu AR; Tsutsui M; Kataoka H; Joh T; Johnston RN
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.